Cingulate Therapeutics

1 follower

‌

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.

Industries

Pharmaceutical

Headquarters

Kansas City, United States

Employees

11-50

Links

Org chart

Shane J. Schaffer

Chairman & CEO

Shane J. Schaffer

Collapse

Raul R. Silva

Chief Science Officer

Matthew Brams

Chief Medical Officer

Arthur Straughn

Co-founder Board of Directors

Jeff Bennett

Deputy General Counsel

Naama Courtemanche

Vp, Operations And Quality Assurance

Thomas Dalton

Vice President, Investor & Public Relations; Vice President, Government Affairs

Jennifer Callahan

Svp, Chief Financial Officer

Teams

Advisory Team

11 members

Leadership Team

3 members

Operations and Administration

4 members

Similar companies

Curia Global

4 followers

SurveyMonkey

81 followers

Earth Advantage

56 followers

Empora Title

1 follower

E Source

5 followers

ObvioHealth

4 followers

Synthekine

3 followers

RedesignGroup

3 followers

Lenz Therapeutics

3 followers

cGMP Validation LLC

1 follower

Casca

3 followers

Explore companies